Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in TurkeyKadriye Başkurt, Orhun Akdoğan, Yasemin Sağdıç Karateke, et al.
International Journal of Cancer|June 18, 2026
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial)Kadriye Başkurt, Galip Can Uyar, Enes Yeşilbaş, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 14, 2025
Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)İlknur Deliktaş Onur, Pınar Akdur Özdemir, Orhun Akdoğan, et al.
The Lancet Regional Health. Europe|July 17, 2025
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scoresGalip Can Uyar, Oriol Mirallas, Kadriye Başkurt, et al.
Scientific Reports|March 27, 2026
The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective studyAhmet Oruç, İlknur Deliktaş Onur, Galip Can Uyar, et al.
Journal of Chemotherapy (Florence, Italy)|December 19, 2025
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre studyBilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç, et al.
International Journal of Cancer|October 28, 2025
Efficacy and safety of doxorubicin-ifosfamide versus gemcitabine-docetaxel as first-line therapy in advanced nonuterine leiomyosarcoma: A multicenter real-world studySalih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel, et al.
Discover Oncology|November 17, 2025
Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective studySalih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel, et al.
Pageof 2